[1]
“IL-6/STAT3/ARF: the guardians of senescence, cancer progression and metastasis in prostate cancer”, Swiss Med Wkly, vol. 145, no. 5152, p. w14215, Dec. 2015, doi: 10.4414/smw.2015.14215.